A detailed history of Cetera Trust Company, N.A transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Cetera Trust Company, N.A holds 8 shares of REGN stock, worth $5,614. This represents 0.01% of its overall portfolio holdings.

Number of Shares
8
Previous 8 -0.0%
Holding current value
$5,614
Previous $8.41 Million 0.02%
% of portfolio
0.01%
Previous 0.01%

Shares

1 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 01, 2024

BUY
$775.18 - $881.7 $6,201 - $7,053
8 New
8 $7.03 Million

Others Institutions Holding REGN

About REGENERON PHARMACEUTICALS, INC.


  • Ticker REGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,190,000
  • Market Cap $75.2B
  • Description
  • Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...
More about REGN
Track This Portfolio

Track Cetera Trust Company, N.A Portfolio

Follow Cetera Trust Company, N.A and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Trust Company, N.A, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Trust Company, N.A with notifications on news.